Ensysce Biosciences Inc. (ENSC) - Cekelan dhuwit saben saham

Lambang korporat lan logo Ensysce Biosciences Inc. (ENSC)

Ensysce Biosciences (ENSC) is developing innovative TAAP/MPAR systems to combat the opioid crisis. Ownership of patents for safe analgesics provides high growth potential. However, the lack of sales leaves the company dependent on external financing and FDA verdicts. The cash per share metric illustrates liquidity dynamics, where the 1.53 mark indicates the level of current capital reserves.

Ensysce Biosciences (ENSC) - Dhuwit awis saben saham saka 04.07.2022 nganti 20.11.2026

Rincian analitis perusahaan Ensysce Biosciences

- nilai saham lan prakiraan konsensus rega:
- rincian posisi dhuwit lan arus kas:
Analisis komprehensif perusahaan:Ensysce Biosciences
Produk asil prodhuksi Ensysce Biosciences, Inc.

The development of safe TAAP analgesics requires significant capital expenditures for clinical trials. By analyzing the cash per share chart, an investor assesses the liquidity of Ensysce Biosciences (ENSC). This metric is calculated as the ratio of total cash to the total number of shares outstanding. It determines the actual asset value available to each share. A high level of this indicator guarantees the biotech's financial stability during the period leading up to product commercialization.